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New emm (M Protein Gene) Sequences of
Group A Streptococci Isolated from
Malaysian Patients
To the Editor: We analyzed the M-typespecific
emm gene sequences of 24 random Streptococcus
pyogenes isolates from sterile- and nonsterile-
site clinical specimens of Malaysian patients. In
contrast to isolates in the United States, which
rarely have new emm sequences, 6 of these 24
Malaysian isolates had new emm gene se-
quences, which suggests a large reservoir of
group A streptococci expressing new M-type
specificities in Malaysia.
The M protein is a surface-exposed principal
virulence factor of group A streptococci (GAS)
and a potential vaccine candidate. The
hypervariable M-typespecific N-terminal por-
tion of the M molecule extends from the cell wall
and evokes protective antibodies. Approximately
75 M antigenic types of GAS are recognized, and
several provisional types have been proposed (1).
Formulation of a universally effective vaccine is
complicated by the M-typespecific nature of
protective anti-GAS antibodies, temporal and
geographic variations in GAS M-type prevalence
(2), and lack of information on GAS M types from
areas where rheumatic fever and rheumatic
heart disease, sequelae of GAS pharyngitis, are
endemic (3). The lack of specific M-typing antisera
is also a limiting factor in determining type
distribution. Recently, Beall and colleagues (4,5)
demonstrated that sequence analysis of the
hypervariable portion of the emm gene encoding
M-type specificity (emm typing) was an alternative
when M-typing antisera were not available.
Attempts to type selected Malaysian strains
of GAS by M protein status have yielded poor
results. Fewer than 16% of strains were typable
with standard M-typing antisera (6). The
existence of new M types in Southeast Asia was
suggested as an explanation. To investigate this
possibility, we subjected 27 selected strains (6
from blood, 15 from pharyngitis, 3 from pus, and
3 pharyngeal carrier cultures) collected between
January 1994 and December 1996 to emm
typing. Initial isolation, serogrouping, T typing,
and determination of opacity factor production
were performed in Kuala Lumpur, by standard
techniques, commercial media, reagents, and
antisera (7). Strains were transported to the
Centers for Disease Control and Prevention in
Atlanta, Georgia, USA, for emm typing, where
serogrouping, T typing, and opacity factor
determinations were repeated, and emm typing
was performed (4,5). DNA sequences were
subjected to homology searches against all
known  emm sequences by Genetics Computer
Group Software, Version 9. (Most sequences in
this database were found in strains isolated from
patients living in Europe and North America.)
Of the 27 cultures analyzed, 24 were GAS, 2
were group G streptococci, and 1 was
nongroupable Streptococcus. Ten of the 24 GAS
strains were standard emm types emm3, emm12,
emm22,  emm60, and emm76 (encoding the
classic M types M3, M12, M22, M60, and M76,
respectively); 4 were the provisional emm types
pt180, pt2841, and pt5757; and 3 were previously
identified  emm  sequence types st64/14 and
st2034 (GenBank accession numbers X72932 and
U74320, respectively). The st2034 sequence,
originally identified in children from Papua New
Guinea, has also been found in Brazil, California,
and Hawaii (B. Beall, R. Facklam, unpub. data).
One GAS had a sequence previously found in
group G streptococci (emmLG6, accession
number U25741). Finally, 6 were of five new
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(st4529, st4547, st4532, st4545, and st3018, with
accession numbers AF060368, AF052426,
AF077666, AF077668, and AF077669, respec-
tively). The newly found group A st4545
sequence was more similar to various group G
streptococcal  emm sequences than to known
group A emm sequences. One group G isolate had
a previously found group G 5' emm sequence
(stLG6, accession number U25741). The
nongroupable Streptococcus had an emm
sequence previously associated with group L
Streptococcus (Beall and Facklam, unpub. data).
These results demonstrate the usefulness of
emm typing in areas where specific M-typing
antisera are not available.
Identifying 6 (25%) of 24 GAS with new emm
types provides further evidence of new M
serotypes of GAS in Malaysia. The deduced
amino acid sequences of the mature hypervariable
N termini of ST4529, ST4532, ST4547, and
ST3018 ranged from 43% to 82% identity to M
proteins of known sequence (data not shown).
The M nontypability of these isolates suggests
unique serologic specificity. ST4547, ST4532,
and ST3018 had 70% to 82% identity over the
first 55-variable-region amino acids, with their
closest matching known M proteins (M70, M27,
and M22, respectively), but whether antibodies
against any of these proteins would cross-protect
against strains expressing these M proteins is
unknown. Even though the M70 protein is 70%
identical over its first 50 variable N terminal
amino acids to the M33 protein, antibodies
against the M70 and M33 proteins do not cross-
protect, which suggests that no cross-protection
would occur. The new deduced M protein with
the lowest similarity to any known M protein was
ST4529, whose closest match had a 43% identity
over the N-terminal 55 residues of the M5
protein.  st4529 likely encodes a new
serospecifically unique M protein.
These findings potentially affect vaccine
development. Although new emm sequences
were identified in a survey in the United States
(5), the percentage of new strains with new emm
sequences was much lower (6%) than was found
with these Malaysian isolates. emm typing of a
larger number of strains from rheumatic fever
and rheumatic heart diseaseendemic areas is
required to deduce amino acid sequences for
the development of a suitable M protein
based  vaccine.
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Mutant Chemokine Receptor (CCR-5) and
Its Relevance to HIV Infection in Arabs
To the Editor: Approximately 10% of HIV-
infected patients may remain AIDS-free for a
long time; moreover, some persons do not become
infected with HIV despite multiple high-risk
sexual exposures (1,2). Factors responsible for
this relative resistance to infection and disease
include cytotoxic T cells, neutralizing antibodies,
high concentrations of certain chemokines (e.g.,